Clinical Trial

Predicting Treatment Response in Cervical Cancer

Study Description

MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

This trial studies magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging in predictive treatment response in patients with stage IB-IVA cervical cancer. MRI is a procedure in which radio waves and a powerful magnet linked to a computer are used to create detailed pictures of areas inside the body. PET is a procedure in which a small amount of radioactive glucose (sugar) is injected into a vein, and a scanner is used to make detailed, computerized pictures of areas inside the body where the glucose is taken up. Comparing results of diagnostic procedures, such as MRI and PET, done before, during and after radiation and chemotherapy may help doctors predict a patient's response to treatment and help plan the best treatment.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Procedure - Computed Tomography

Undergo FDG PET/CT

Procedure - Diffusion Weighted Imaging

Undergo DW MRI

Procedure - Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Undergo DCE MRI

Radiation - Fludeoxyglucose F-18

Undergo FDG PET/CT

Procedure - Magnetic Resonance Spectroscopic Imaging

Undergo MR spectroscopy

Procedure - Positron Emission Tomography

Undergo FDG PET/CT

Additional Information

Official Study Title

MRI- and PET-Predictive-Assay of Treatment Outcome in Cancer of the Cervix

Clinical Trial ID

NCT01992861

ParticipAid ID

mbkrYa